8FY6
SARS-CoV-2 main protease in complex with covalent inhibitor
Summary for 8FY6
Entry DOI | 10.2210/pdb8fy6/pdb |
Descriptor | 3C-like proteinase nsp5, (1R,2S,5S)-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-N-{(2R)-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}-3-azabicyclo[3.1.0]hexane-2-carboxamide (3 entities in total) |
Functional Keywords | sars-cov-2 main protease, protease, non-structural protein, covalent inhibitor, viral protein, hydrolase-inhibitor complex, hydrolase/inhibitor |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 1 |
Total formula weight | 34328.12 |
Authors | Fried, W.,Chen, X.S. (deposition date: 2023-01-25, release date: 2023-08-30, Last modification date: 2024-07-24) |
Primary citation | Ngo, C.,Fried, W.,Aliyari, S.,Feng, J.,Qin, C.,Zhang, S.,Yang, H.,Shanaa, J.,Feng, P.,Cheng, G.,Chen, X.S.,Zhang, C. Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main Protease. J.Med.Chem., 66:12237-12248, 2023 Cited by PubMed: 37595260DOI: 10.1021/acs.jmedchem.3c00810 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report